Cancer Research UK reports immunotherapy drug that can extend life of cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects, according to preliminary results from a late stage clinical trial. “This is another great example of how research into the immune system can deliver powerful new treatments” – Professor Peter Johnson, Cancer Research UK. Patients with

Continue Reading

NHS England unveils investment in cancer services

Chief executive of NHS England, Simon Stevens, has unveiled the first fraction of hospitals that will benefit from a major national investment in NHS radiotherapy machines.   Fifteen hospitals in areas where there is greatest need have now been selected to receive new LINAC linear (accelerator) machines, as part of a £130-million investment in radiotherapy

Continue Reading

Number of Prescribed Antibiotics Has Fallen for the First Time in England

Doctors in England have prescribed 2.2 million less antibiotics between 2014 to 2015. Data from Public Health England has shown a significant reduction of 40.7 million to 38.5. A report by the ‘English Surveillance Programme for Antimicrobial Utilisation and Resistance’ (ESPAUR) stated the 4.3 percent decline in antibiotic prescriptions has been noted to be the

Continue Reading

Lung function test used to diagnose COPD can aid patients whilst reducing healthcare costs

According to a recent study by the Canadian Medical Association Journal (CMAJ), patients with chronic obstructive pulmonary disease (COPD) would benefit greatly if pulmonary function testing was used more consistently when diagnosing the condition. COPD is currently the third principal cause of death worldwide and affects over 10% of adults. At the moment, testing airflow

Continue Reading

New EU study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients

Results from a survey analysing the prescribing behaviour of 500 European physicians treating patients with advanced non-small cell lung cancer (NSCLC) have been published in Clinical Lung Cancer. The research examined the primary therapy goal of physicians and their choice of treatment for patients with advanced adenocarcinoma of the lung, after first-line chemotherapy. An overview

Continue Reading